Results 181 to 190 of about 31,041 (297)

The Application of Artificial Intelligence and Machine Learning in Left Ventricular Assist Device Implantation: A Systematic Review

open access: yesArtificial Organs, EarlyView.
This systematic review explores the application of artificial intelligence and machine learning in left ventricular assist device implantation, highlighting their superior accuracy in predicting mortality, adverse events, myocardial recovery, thrombosis risk, and right ventricular failure. Despite promising outcomes, challenges like data heterogeneity,
Usama Hussain   +7 more
wiley   +1 more source

Impact of spontaneous recanalization of occlusive cervical artery dissection on risk of stroke. [PDF]

open access: yesJ Neurol
Mayer-Suess L   +10 more
europepmc   +1 more source

The incidence of serious complications after selective laser trabeculoplasty

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT). Methods All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018.
Eeva S. Ojanen   +2 more
wiley   +1 more source

Incidence, risk factors, and outcomes of numerical hypotony and choroidal effusion following PRESERFLO MicroShunt implantation

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the incidence, outcomes, and risk factors of numerical hypotony (NH) and choroidal effusion (CE) following standalone PRESERFLO MicroShunt (PMS) implantation. Methods Primary open‐angle glaucoma (POAG) and pseudoexfoliative glaucoma (PXG) patients with uni‐ or bilateral surgery at a tertiary university hospital were ...
Emil Nasyrov   +5 more
wiley   +1 more source

Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization [PDF]

open access: bronze, 2000
Sylvia Bellucci   +10 more
openalex   +1 more source

Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia

open access: yesBritish Journal of Haematology, EarlyView.
Summary Ibrutinib is metabolized by cytochrome P450 3A (CYP3A) and poses challenges with drug interactions. We conducted a population‐based cohort study of Ontario residents aged ≥66 years who initiated ibrutinib for chronic lymphocytic leukaemia (CLL) to evaluate the frequency of potential drug interactions involving moderate/strong CYP3A inhibitors ...
Tuan Hoang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy